ArticleInternational journal of clinical oncology2022

The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer.

Tomoyuki Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.